应用 |
An M3 muscarinic acetylcholine receptor blocker. |
产品介绍 |
Darifenacin HBr是一种选择性的M3 muscarinic(M3蕈毒碱)受体拮抗剂,pKi为8.9。 |
备注 |
Darifenacin is a selective M3 muscarinic receptor antagonist with pKi of 8.9. |
生化机理 |
Darifenacin hydrobromide is an antispasmodic muscarinic antagonist, selective for blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions. Darifenacin hydrobromide has 9 and 12-fold greater affinity for M3 compared to M1 and M5, respectively, and 59-fold greater affinity for M3 compared to both M2 and M4. Darifenacin is used clinically to treat urinary incontinence and overactive bladder syndrome. |
别名 |
氢溴酸达非那新; {1-[2-(2,3-二氢苯并呋喃-5-基)乙基]-3-吡咯烷基}-2,2-二苯基乙酰胺氢溴酸盐;UK 88525-04;Enablex;Darifenacin hydrobromide;(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide hydrobromide ;UK 88525-04;{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide;Diphenyl-acetamide hydrobromide |